Back to search
FDAFDA · Food and drugs·Recall number D-0540-2023

Pantoprazole sodium for Injection 40 mg*/vial, Single-dose Vial, Rx only, For Intravenous Infusion Only, Mfd. for Methapharm, Inc. Coral Springs, FL, 33065, NDC 67850-150-10 (carton), NDC 67850-150-00 (vial).

Published May 3, 2023 · Recall initiated: April 7, 2023

Summary

FDA records drug Class II recall D-0540-2023, published May 3, 2023 and initiated April 7, 2023. Recalling firm: Methapharm Inc; Status: Completed; Reported quantity: 5377 cartons; Lot: Lots: 220801; 220802; 220803 Exp. July 2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Methapharm Inc
Distributor
Nationwide in the USA
Lot
Lots: 220801; 220802; 220803 Exp. July 2024
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pantoprazole sodium for Injection 40 mg*/vial, Single-dose Vial, Rx only, For Intravenous Infusion Only, Mfd. for Methapharm, Inc. Coral Springs, FL, 33065, NDC 67850-150-10 (carton), NDC 67850-150-00 (vial). recalled?

Yes. FDA published recall D-0540-2023 on May 3, 2023. Reported hazard: CGMP Deviations; The impacted product and lot number was inadvertently placed into saleable inventory, which does not comply with approved procedures.

What should I do if I have this product?

Voluntary: Firm initiated · Letter